SPY366.69-0.10 -0.03%
DIA300.06+0.88 0.29%
IXIC12,377.18+27.82 0.23%

Morgan Stanley Maintains Equal-Weight on Y-mAbs Therapeutics, Raises Price Target to $45

Morgan Stanley maintains Y-mAbs Therapeutics (NASDAQ:YMAB) with a Equal-Weight and raises the price target from $42 to $45.

· 11/12/2020 08:16
Morgan Stanley maintains Y-mAbs Therapeutics (NASDAQ:YMAB) with a Equal-Weight and raises the price target from $42 to $45.